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According to the Substance Abuse and Mental Health Services 
Administration (SAMHSA), an estimated 312,000 people in Oregon are 
diagnosed with Substance Use Disorder (SUD)(2019a, line 28). “Substance 
use disorders occur when the recurrent use of alcohol and/or drugs causes 
clinically significant impairment, including health problems, disability, and 
failure to meet major responsibilities at work, school, or home” (SAMHSA, 
2019b, para. 4). People with SUD are at a higher risk for infections from 
unsafe injection practices. 
Infective endocarditis (IE) is one such life-threatening infection resulting from 
IV drug use. People with SUD and IE require hospitalization and long-term 
antibiotics. There are limited publications about the care of hospitalized 
patients with both SUD and IE. 
Two studies from research hospitals located in Massachusetts and Oregon 
support a need for a systematic team-based care model (Rosenthal, et al., 
2016; and Englander, et al., 2017). Both of these studies recommend 
medication-assisted treatment (MAT) for the patient while hospitalized to 
decrease the drug dependence and continue the MAT at the time of 
discharge. Medications used include buprenorphine/ naloxone and 
methadone. In addition to the use of medications, a Trauma Informed Care 
(TIC) model is advised in caring for this patient population. U.S. Department 
of Health and Human Services, SAMHSA defines trauma as: “Individual 
trauma results from an event, series of events, or set of circumstances this is 
experienced by an individual as physically or emotionally harmful or life 
threatening and that has lasting adverse effects on the individual’s 
functioning and mental, physical, social, emotional, or spiritual well-
being”(2014, p. 7). 
This Institutional Review Board (IRB) approved study is a retrospective 
chart review of adult SUD patients with infective endocarditis 
discharged from either of the two cardiology units at PSVMC from 
January 1, 2016 to December 31, 2018. A list generated from the 
electronic medical record identified patients with ICD-10 codes for both 
SUD and IE. 
This study identifies gaps in admission screening, in-hospital treatment for 
drug use, and discharge planning related to SUD patients admitted with 
IE. 
Not every patient had a urine toxicology screen on admit. In addition, no 
current screening tool, risk assessment, or model of care existed for this 
population. During their stay no pathway bundle existed. No substance 
use physician was available to prescribe a medicated assisted treatment 
(MAT) or facilitate a treatment plan upon discharge. Gaps in discharge 
also included no patients discharging to an in-patient drug rehab center. 
This study supports the need to improve care for this vulnerable 
population by developing a systematic team-based care model. 
Recommendations to improve care would be to collaborate with our 
interdisciplinary team to create a care pathway bundle for patients 
diagnosed with SUD and IE. This pathway bundle will include standard 
care practices written into policy that will use a screening tool for 
identifying these patients, TIC education for caregivers, a patient 
agreement upon admission, urine toxicology screen upon admission, 
consultation with a substance abuse physician, and close follow up with 
social work. 
Limitations for this study include a small sample size of 29 patients and 
the chart review process. The study population was found using ICD 10 
Codes in the electronic medical record. As a result the study population 
may underrepresent the number of patients with SUD and IE. Missed 
opportunities include the inability to include social work in reviewing the 
study population and lack of post-hospital follow-up data. We were also 
unable to collaborate follow-up care, as many patients did not have strong 
follow-up care documentation. The study only followed our patients for 6 
months post discharge. Despite the limitations this study does provide 
information that can be used for initiating interventions for this population.
Further research will need to be done once a Standard of Care is 
implemented. The research and data would suggest that a best practice 
standardized approach with an addictions team is warranted, and that 
addicted patients be treated by this team. 
Background References
Methods
Results Discussion/Conclusions
A total of 29 patients met inclusion criteria. Of those 29 patients, 16 (55%) 
were male, 13 (45%) were female, and had a mean age of 34.4 ± 10.4 
years. Seventeen (59%) patients were reported as homeless on admission. 
The average length of stay was 17.03 days ± 20.1 days with a minimum of 
2 and a maximum of 93 days. 
“IE is an infection caused by  bacteria that enter the bloodstream and settle 
in the heart lining, a heart valve or blood vessel.” (American Heart 
Association, 2019). Of the valves affected, 4 (14%) had the aortic valve 
affected, 18 (62%) had the tricuspid valve, 0 (0%) had the pulmonary valve, 
3 (10%) mitral valve, and 4 (14%) had more than one valve affected. 
Methicillin-Susceptible Staphylococcus Aureus was the predominant 
organism identified, accounting for 6 (35%) of patients. No Organisms 6 
(21%). Multiple organisms, 6 (21%). Streptococcus 2 (7%). Candida 
parasilosis 2 (7%). Methicillin-resistant Staphylococcus Aureus 1(3%). 
Enterococcus faecilis 1 (3%). Serratia marcescens 1 (3%). Of these 
patients, 15 (52%) received valve replacement and/or repair, and 7 (24%) 
had more than one surgery.
A total of 25 patients (86%) had a urine toxicology screen on admission. 
None of the patients in the study received services from addictions provider 
or addiction-specific team while at PSVMC. Only 8 (28%) of patients were 
discharged on MAT with Suboxone or methadone. Additionally, 0 (0 %) of 
the sample size went to inpatient substance abuse rehabilitation centers. 
Fourteen patients (48%) discharged home, which included personal home, 
friend or family home, or shelter; 7 (24%) were discharged to Skilled 
Nursing Facilities, 6 (21%) were unhoused,2 (7%) died. Of the 29 patients, 
5 (21%) left against medical advice regardless of discharge location.
Readmission was defined as a readmit to any Providence facility within a 
six-month window following the discharge. Fourteen (48%) patients 
readmitted. 
Purpose
The purpose of this study is to perform a retrospective chart review, 
first to better understand the hospital care provided to SUD with IE 
patients at Providence St. Vincent Medical Center (PSVMC), a 523-
bed tertiary care facility with a cardiac center of excellence, and then 
identify improvement opportunities. 
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